|
|
Article: Other News To Note.(Advanced Biological Laboratories entered into a patent licensing agreement with Viralliance Inc.)(Alsace BioValley is constructing a new building)(Introgen Therapeutics Inc. is cutting 20 employees )
- Article from:
- BIOWORLD Today
- Article date:
- July 8, 2008
CopyrightCOPYRIGHT 2008 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ABL Patent Licensing Technologies SARL, a subsidiary of Advanced Biological Laboratories SA, of Luxembourg, Belgium, entered into a patent licensing agreement with Viralliance Inc., of Paris. ABL has granted a non-exclusive, royalty-bearing license to Viralliance to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. Financial details were not disclosed.
Alsace BioValley, of Strasbourg, France, is constructing a new building to house the Center for Integrative Biology as well as a platform center serving research and industry. The project will be piloted by the Alsace Region and aims to provide on a ...